News

NeuroRx, Inc., in partnership with RELIEF THERAPEUTICS Holding AG announced that the U.S. Food and Drug Administration (FDA) awarded Fast Track designation to NeuroRx for the…
Read More...

Replicate Bioscience, Inc. and Immunomic Therapeutics, Inc. announced that the companies have entered into a research and licensing option agreement to combine their platform…
Read More...

Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will utilize Thermo Fisher's…
Read More...

Novaremed AG (Novaremed), a clinical-stage Swiss biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND)…
Read More...

Linnaeus Therapeutics, Inc. (Linnaeus) announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, have agreed to expand their existing 2018…
Read More...

Gilead Sciences, Inc. announced that for $275 million the company will acquire a 49.9 percent equity interest in Pionyr Immunotherapeutics Inc., a privately held company developing…
Read More...

Century Therapeutics announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM). “We are pleased to welcome…
Read More...

Agenus Inc. announced that it has entered into an agreement with Betta Pharmaceuticals, a top Chinese pharmaceutical company focusing on the development of innovative oncology…
Read More...

Sarepta Therapeutics, Inc. and Codiak BioSciences, Inc. announced a global research and option agreement to design and develop engineered exosome therapeutics to deliver gene therapy,…
Read More...

Piramal Enterprises Limited's (PEL) Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), announced that the Company has entered into an…
Read More...

Ascentage Pharma announced a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca. Under the terms of the…
Read More...

Merck, known as MSD outside the United States and Canada, announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in…
Read More...

Alpine Immune Sciences, Inc. and AbbVie Inc. announced an exclusive worldwide option and license agreement for ALPN-101, a first-in-class dual CD28/ICOS costimulation antagonist.…
Read More...

Sarepta Therapeutics and Selecta Biosciences, Inc. announced that they have entered into a Research License and Option agreement granting Sarepta an option to license the rights to…
Read More...

Roche announced that the Phase III IMpassion031 study, evaluating Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane, albumin-bound paclitaxel; nab-paclitaxel; followed…
Read More...

Neurocrine Biosciences, Inc. and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialize compounds in Takeda’s early-to-mid-stage…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA),…
Read More...

Orca Bio, a clinical-stage biotechnology company developing high precision allogeneic cell therapies, announced a Series D financing that brings its total capital raised since its 2016…
Read More...